back to Meetings page
  • IMMPACT-XIV
  • June 16-17, 2011
  • Ritz Carlton Pentagon City
  • Arlington, Virginia

  • Co-chairs:
  • Dennis C. Turk, PhD (University of Washington)
  • Robert H. Dworkin, PhD (University of Rochester)
  • Academia and Related Participants
  • Dorcas Beaton, PhD (University of Toronto)
  • Nicholas Bellamy, MD (University of Queensland)
  • Christopher Eccleston, PhD (University of Bath)
  • Susan Ellenberg, PhD (University of Pennsylvania)
  • Scott Evans, PhD (Harvard School of Public Health)
  • Roy L. Freeman, MD (Harvard University)
  • John T. Farrar, MD, PhD (University of Pennsylvania)
  • Louis Garrison, PhD (University of Washington)
  • Alejandro Jadad, MD, DPhil (University of Toronto)
  • Mark P. Jensen, PhD (University of Washington)
  • Cornelia Kamp, MBA (University of Rochester)
  • Nathaniel P. Katz, MD (Analgesic Solutions and Tufts University)
  • John D. Markman, MD (University of Rochester)
  • Michael McDemott, PhD (University of Rochester)
  • Philip J. Mease, MD (University of Washington)
  • Alec B. O'Connor, MD (University of Rochester)
  • Srinivasa N. Raja, MD (Johns Hopkins University)
  • Michael C. Rowbotham, MD (California Pacific Medical Center)
  • Cristina Sampaio, MD, PhD (Faculdade de Medicina de Lisboa)
  • Stephen Senn, PhD (University of Glasgow)
  • David Schoenfeld, PhD (Harvard Medical School)
  • Jasvinder Singh, MD (University of Alabama)
  • Vibeke Strand, MD (Stanford University)
  • Ajay D. Wasan, MD (Harvard Medical School)
  • Hilary D. Wilson, PhD (University of Washington)
  • Government Participants
  • Laurie B. Burke, RPh, MPH (US Food and Drug Administration)
  • Ann Costello, DMD, PhD (US Food and Drug Administration)
  • Catherine Gray, PharmD (US Food and Drug Administration)
  • Linda Porter, PhD (National Institutes of Health)
  • Bob A. Rappaport, MD (US Food and Drug Administration)
  • Patient Representative
  • Penney Cowan (American Chronic Pain Association)
  • Industry Participants
  • Zubin Bhagwagar, MD, PhD (Bristol-Myers Squibb)
  • Jens Cronlein, MD (Boehringer-Ingelheim)
  • Veerainder Goli, MD, MBA (Pfizer)
  • Smriti Iyengar, PhD (Eli Lilly)
  • Roderick Junor, PhD, MB (Eisai Limited)
  • J. Patrick Kesslak, PhD (Allergan)
  • Ernest Kopecky, PhD, MBA (Endo Pharmaceuticals)
  • Dmitri Lissin, MD (Durect Corporation)
  • Christine Rauschkolb, MD, PhD (Johnson & Johnson)
  • Ilona Steigerwald, MD, PhD (Grunenthal GmbH)
  • Jeffrey Tobias, MD (NeurogesX)